LIVANOVA USA, INC.

Lobbying for LIVANOVA USA, INC.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $140,000.00 expenses · posted Apr 20, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare beneficiary access to treatments for depression and epilepsy. Issues related to Medicare beneficiary access to procedures performed in ambulatory surgical centers. Issues related to Medicare Prior Authorization.

Health Issues

Issues related to epilepsy. Issues related to telehealth.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.